Navigation Links
Women Deliver Conference Launches New Commitments
Date:10/20/2007

s reproductive health worldwide; a US$11 million investment by the John D. and Catherine T. MacArthur Foundation in distributing new technology against blood loss after childbirth in Nigeria and India; and a commitment from Japan to put global health at the centre of the Group of Eight summit meeting in Japan next year.

Pledges of further action also came from the David & Lucile Packard Foundation, the Bill and Melinda Gates Foundation, the International Labour Organisation, the United Nations Foundation, UNICEF, Exxon/Mobil, and GlaxoSmithKline.

Advocates for women's health should seek to work both within governments and as non-governmental organization activists, said Dr. Helene Gayle, president of CARE. "We need people both on the inside and the outside to figure out how to work together to get these things to happen," she said. "NGOs can't do it by themselves."

Earlier commitments to the goals of Women Deliver included pledges of US$1 billion from Norway for the Global Campaign for the Health MDGs, (http://www.norad.no) an initiative to secure achievement of the MDGs to improve child health and reduce disease, as well as the maternal health goal. The Netherlands pledged 125 million Euros (about US$178 million) for gender equality and maternal health, and Denmark pledged 110 million kroner (US$21 million) for HIV/AIDS and reproductive health.

"Increased and dependable financing would make a big difference in saving the half a million mothers who die each year in pregnancy or when giving birth," said Morten Wetland, secretary of state for Norway's Prime Minister Jens Stoltenberg.

"All national, regional and international leaders must recognize that the achievement of the MDGs as a whole, and improvement of health systems more broadly, depend largely on achieving MDGs 4 and 5," the ministers' statement said.


'/>"/>
SOURCE Women Deliver
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Starvation in pregnant women can cause heart disease to their children
4. Women suffer from sexual dysfunction too
5. Brisk Walking lowers memory loss in women
6. Young womens woes
7. Young womens woes
8. Women find difficulty in calling it Quits
9. FDA approves new device to treat womens bleeding disorder
10. Women recognise faces better
11. Women more susceptible to brain damage from ecstasy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is ... in Birmingham. The U.S. Women's National Soccer Team will face the Australia Women's National ... Thursday, September 17th at Ford Field in Detroit and the second match will occur ...
(Date:7/31/2015)... ... ... Awarded to only the Top 10 hair transplant practices in the United ... recipients of the Center of Clinical Excellence for ARTAS Robotic Hair Transplantation . ... science of hair transplant. , Parsa Mohebi Hair Restoration is known worldwide for their ...
(Date:7/31/2015)... ... 31, 2015 , ... everMaya ( http://evermaya.com/ ), a Fashion ... will be named for Madeline Stuart, an 18-year-old model from Brisbane, Australia. Ms. ... with Down syndrome, gracing the front pages of publications across the world. everMaya ...
(Date:7/31/2015)... ... July 31, 2015 , ... Indosoft, Inc., is pleased ... in Q-Suite 5.9. Q-Suite is their flagship contact center ACD system for Asterisk-based ... script display logic shows the script components to the agent only when wanted, and ...
(Date:7/31/2015)... Detroit, MI (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable ... The U.S. Women's National Soccer Team will face the Australia Women's National Team in conjunction ... by a score of 5-2. Carli Lloyd from the USA team was awarded the ...
Breaking Medicine News(10 mins):Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:everMaya to Launch Madeline Stuart Handbag Line 2Health News:everMaya to Launch Madeline Stuart Handbag Line 3Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2
... growing brain tumors must adjust to periods of low ... cells grow and proliferate. When levels are low, the ... Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer ... the switch responsible for this grow-or-go behavior. , Their ...
... that the company received Registration Certificate for its MEVAC-Vari vaccine in Guatemala . , ... , , ... ... ...
... author, and lecturer Dr. William Sears and his product team have announced the launch of ... Expo West convention to be held in Anaheim, CA March 12-14 . The company,s ... ... ...
... ... and food security has wide-ranging benefits compared to its costs in the fight against ... Congressional hearing on global hunger. He cites findings from Nobel laureates and a Lancet ... ...
... ... ... 11, 2010 -- Qualifacts Systems Inc. , the largest Software as a Service ... and human services providers, has added New Directions Inc. to its client roster – ...
... ... President of International Orion Health – Charles Scatchard. Orion Health celebrates “phenomenal success” with ... , ... (PRWEB) March 12, 2010 -- To further the ongoing success with implementing Healthcare IT ...
Cached Medicine News:Health News:Researchers discover brain tumor's 'grow-or-go' switch 2Health News:Researchers discover brain tumor's 'grow-or-go' switch 3Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 2Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 3Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 4Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 5Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 2Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 3Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 2Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 3Health News:Qualifacts is Behavioral Health SaaS Provider of Choice in Connecticut 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 3Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 4Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 5
(Date:7/31/2015)... 2015  Semler Scientific, Inc. (Nasdaq: SMLR ), ... healthcare insurers and physician groups, today reported financial results ... "In the second quarter of 2015, Semler ... of 54%, quarter over quarter revenue growth of 8%, ... of FloChec® units of 18%," said Doug Murphy-Chutorian, M.D., ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... antibodies for the treatment of autoimmune diseases, asthma and ... Yujiro S. Hata to its board of ... business and corporate development is a tremendous asset to ... and chief executive officer of Xencor. "Xencor faces a ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... - the novel,selective relaxant binding agent (SRBA) being ... Akzo Nobel - demonstrated in,a Phase III pivotal ... as compared to neostigmine, without evidence,of post operative ... The results of this pivotal Aurora trial,were presented ...
... 11, 2007 (MARKET WIRE via COMTEX News,Network) ... target=,"_blank" href="http://www.myriad.com/">www.myriad.com ),announced today that it presented ... a "Randomized Withdrawal" clinical trial,design with a ... the Alzheimer's Association Prevention Conference held,June 9 ...
Cached Medicine Technology:Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 2Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5
PremierEdge™ Stab Knives - 45°....
PremierEdge Stab Knives - 15....
More Info Lacrimal Intubation Set. Size: Probes 23g x 7"....
... use of the Leica CM1900 as well ... the instrument of choice in many routine ... open top stainless steel cryochamber with separate ... ample space for convenient working and storage ...
Medicine Products: